Sirio Europe Overview
- Founded
-
1992

- Status
-
Acquired/Merged
- Employees
-
39

- Latest Deal Type
-
M&A
- Financing Rounds
-
7
- Investments
-
1
Sirio Europe General Information
Description
Producer of pharmaceutical private label products designed to develop nutraceutical and dietary supplements. The company's products include arctic nutrients, and food supplements in the form of Omega3 formulations, offers a proven track record of formulation, private labeling, custom packaging, and distribution system to the global health industry, enabling consumers to have healthy and mineral-rich supplements without any side effects.
Contact Information
Website
www.sirio-europe.com
Formerly Known As
ProBio, Ayanda
Ownership Status
Acquired/Merged
(Operating Subsidiary)
(Operating Subsidiary)
Financing Status
Formerly PE-Backed
Primary Industry
Pharmaceuticals
Parent Company
Sirio Pharma
Primary Office
- Am Hünengrab 20
- 16928 Pritzwalk
- Germany
+49 033986 0000
Sirio Europe Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Sirio Europe Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Financing
Details
Producer of pharmaceutical private label products designed to develop nutraceutical and dietary supplements. The company
Pharmaceuticals
Pritzwalk, Germany
39
As of 2021
00.000
000000&0
00.000
Sirio Europe Competitors (3)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
FabRx (Pharmaceuticals) | Corporation | London, United Kingdom | 0 | 0000000000 | ||
0000000 (0000 0000 | Venture Capital-Backed | Blue Ash, OH | 00 | 00000 | 00000000000 | 00000 |
00000000 0000 | Venture Capital-Backed | San Francisco, CA | 00 | 000.00 | 0000000000 0 | 000.00 |
Sirio Europe Patents
Sirio Europe Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
GB-202202754-D0 | Compositions | Pending | 28-Feb-2022 | 000000000 | |
EP-4134072-A1 | Soft capsule shell and soft capsule | Pending | 28-Jun-2021 | 0000000000 | |
EP-4134072-A4 | Soft capsule shell and soft capsule | Pending | 28-Jun-2021 | 0000000000 | 0 |
AU-2021416460-A1 | Soft capsule shells and soft capsules | Pending | 28-Jun-2021 | 0000000000 | |
CA-3167596-A1 | Soft capsule shells and soft capsules | Pending | 28-Jun-2021 | A61K9/4816 |
Sirio Europe Executive Team (11)
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Minming Xu | Managing Director & Finance Director | ||
Dominique Baum | Managing Director | ||
Per-Oluf Olsen | Board Member & Partner |
Sirio Europe Board Members (9)
Name | Representing | Role | Since |
---|---|---|---|
00000 0000000 | Self | Chairman | 000 0000 |
000-0000 00000 | Self | Board Member & Partner | 000 0000 |
Sirio Europe Signals
Sirio Europe Former Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
Sirio Europe Acquisitions (1)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
0000000 | 08-Jul-2008 | 0000000000 | Pharmaceuticals | 000 00000 |